hTERT启动子调控下CD137L表达载体的构建及其在卵巢癌细胞中的表达

山东大学学报(医学版)

hTERT启动子调控下CD137L表达载体的构建及其在卵巢癌细胞中的表达

张溪¹，崔保霞¹，马道新²，孔北华¹

山东大学齐鲁医院 1.妇产科； 2.血液病研究室，济南 250012

收稿日期:2007-11-12 修回日期:1900-01-01 出版日期:2007-12-24 发布日期:2007-12-24
通讯作者: 崔保霞

Construction and expression of the vector of CD137L under the control of hTERT promoter in human ovarian tumor cell lines

ZHANG Xi¹， CUI Bao-xia¹， MA Dao-xin²， KONG Bei-hua¹

1. Department of Gynecology and Obstetrics; 2. Institute of Hematology, Qilu Hospital of Shandong University， Jinan 250012, China

Received:2007-11-12 Revised:1900-01-01 Online:2007-12-24 Published:2007-12-24
Contact: CUI Bao-xia

摘要/Abstract

摘要： 目的研究hTERT启动子调控下CD137L表达载体的构建及其在人卵巢癌细胞系中的表达，探讨CD137L靶向基因治疗的可行性。方法采用RT-PCR法从K562细胞中克隆CD137L全长基因, 将其克隆到真核表达载体pcDNA3中，构建的质粒为pcDNA3-hCD137L，用Hind Ⅲ和Xba Ⅰ双酶切后将CD137L再定向插入pBTdel-279中，构建成hTERT启动子调控下CD137L表达载体pBTdel-279-hCD137L，采用酶切法和测序法鉴定。用Fugene6转染试剂盒将两种重组质粒分别瞬时转染人卵巢癌细胞株OVCR3和人胚肺成纤维细胞株HELF，RT-PCR和流式细胞仪检测CD137L的表达。结果测序证实所克隆的CD137L基因序列与GENEBANK中的序列相符。经限制性内切酶酶切，电泳后显示片段插入正确，证实构建成功。pcDNA3-hCD137L转染后OVCR3细胞和HELF细胞均可检测到CD137L的表达，但pBTdel-279-hCD137L转染后仅在OVCR3细胞中检测到其表达，在HELF细胞中无表达。流式细胞显示pBTdel-279-hCD137L转染效率低于pcDNA3-hCD137L。结论hTERT启动子调控下CD137L表达载体构建正确，并可在卵巢癌细胞中较高表达，为探讨靶向基因治疗提供了实验依据，但hTERT启动子活性仍低于CMV启动子

关键词: 基因疗法 , CD137L, 人端粒酶逆转录酶, 卵巢肿瘤

Abstract: ObjectiveTo construct an expression vector of CD137L under the control of hTERT promoter and to investigate the expression of this gene in human ovarian tumor cell lines and the possibility of the targeted gene therapy of CD137L. MethodsThe CD137L gene was cloned from the K562 cell lines and was inserted into the pcDNA3 vector to form a new plasmid named pcDNA3-hCD137L. The plasmid was digested by Hind Ⅲ and Xba Ⅰ, then the CD137L fragment was inserted into the pBTdel279 plasmid to get a new plasmid pBTdel-279-hCD137L, in which the expression of CD137L was under the control of hTERT promoter. The new plasmid was identified by digestion of restriction enzyme and sequencing. pcDNA3-hCD137L and pBTdel-279-hCD137L plasmids were transfected into human ovarian tumor cell line OVCR3 and human embryonic lung fibroblast cell line HELF. The expression of hCD137L was determined by RT-PCR and flow cytometry. ResultsThe plasmids were properly constructed. Both OVCR3 and HELF cell lines can express hCD137L after transfection with pcDNA3-hCD137L plasmids, but only OVCR3 cell line can expression hCD137L gene after transfection with pBTdel-279-hCD137L plasmids. The results of flow cytometry showed that the transfection efficiency of pBTdel-279-hCD137L was much lower than that of the pcDNA3-hCD137L plasmid. ConclusionsThe expression vector of CD137L under the control of hTERT promoter is successfully constructed and the expression of hCD137L gene can be targeted in tumor cells by the hTERT promoter. But the activity of hTERT promoter is much lower than that of the CMV promoter. How to increase the activities of the hTERT promoter needs further investigation.

Key words: Ovarian neoplasms, CD137L, human telomerase reverse transcriptase, Gene therapyCD137（4-1BB）

中图分类号:

R737.31

张溪,崔保霞,马道新,孔北华 . hTERT启动子调控下CD137L表达载体的构建及其在卵巢癌细胞中的表达[J]. 山东大学学报(医学版), 2007, 45(12): 1224-1228.

ZHANG Xi,CUI Bao-xia,MA Dao-xin,KONG Bei-hua. Construction and expression of the vector of CD137L under the control of hTERT promoter in human ovarian tumor cell lines[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(12): 1224-1228.

参考文献

相关文章 15

[1]	王伟王沂峰张岭梅林琼燕黄菊. 人卵巢癌OVCAR3细胞系中侧群细胞的分离及其成瘤性、侵袭性的实验研究[J]. 山东大学学报(医学版), 2209, 47(6): 8-11.
[2]	张士宝刘庆勇阮喜云陈杰张建军李宗武杨广笑王全颖. NT₄-SAC-HA₂-TAT融合基因表达载体的构建及鉴定[J]. 山东大学学报(医学版), 2209, 47(6): 15-19.
[3]	赵路,矫俊,张腾,焦薪霖,崔保霞. 肝X受体在卵巢癌组织中的表达及T0901317在卵巢癌细胞系SKOV3中的作用[J]. 山东大学学报（医学版）, 2017, 55(1): 49-53.
[4]	肖俊超,蒋雯,南慧,王培荣. 重组腺病毒35型纤毛突蛋白增强西妥昔单抗的抗卵巢癌作用[J]. 山东大学学报（医学版）, 2016, 54(5): 1-5.
[5]	张春霞,邹存华,宋冬冬,余江. P38MAPK信号通路对卵巢癌中尿激酶型纤维蛋白酶原激活剂的影响[J]. 山东大学学报（医学版）, 2016, 54(2): 68-74.
[6]	吕树卿, 尉蔚, 张灿灿, 田永杰. HGF/PARP-1信号通路调控卵巢癌细胞侵袭转移的作用[J]. 山东大学学报（医学版）, 2015, 53(7): 1-7.
[7]	崔勇, 张荣香, 王福立, 王国颖, 冯建林, 张海霞. BSD2000相控阵聚焦深部热疗联合TP方案化疗治疗晚期卵巢癌的临床效果[J]. 山东大学学报（医学版）, 2015, 53(7): 53-57.
[8]	周静, 常晓天, 周婷, 崔莹莹, 张蓓, 荣风年. 沉默PADI4基因对卵巢癌细胞系OVCAR3的作用[J]. 山东大学学报（医学版）, 2015, 53(6): 48-53.
[9]	陈静, 李春艳, 赵苗青, 崔京睛, 张娜, 傅艺冰. EZH2蛋白在卵巢上皮性肿瘤中的表达及其作用[J]. 山东大学学报（医学版）, 2015, 53(2): 65-70.
[10]	任洪波, 刘海南, 刘承, 颜克强, 夏传友, 范医东. 肾癌尿沉渣中人端粒酶逆转录酶基因启动子区甲基化检测的临床意义[J]. 山东大学学报（医学版）, 2015, 53(1): 73-76.
[11]	宗丽菊, 张友忠, 王颉, 吴淑霞, 刘洪丽, 张璐. 四甲基吡啶卟啉-光动力疗法对人宫颈永生化上皮H8细胞的作用[J]. 山东大学学报（医学版）, 2015, 53(1): 21-26.
[12]	王颉, 张友忠, 冯进波, 刘洪丽, 宗丽菊. 慢病毒介导的hTERT-shRNA联合光动力治疗对宫颈癌细胞SiHa的影响[J]. 山东大学学报（医学版）, 2015, 53(1): 27-33.
[13]	付伟1，高文娟2，张志勉1，曲迅2，赵玉霞3. 罗勒多糖对卵巢癌SKOV3细胞VEGF受体表达的调控作用及对其侵袭能力的影响[J]. 山东大学学报（医学版）, 2014, 52(5): 39-43.
[14]	周静, 郑亚冰, 闫莉, 常晓天, 赵珊, 荣风年. 雌激素及顺铂对卵巢癌细胞A2780PADI4的表达及其细胞增殖的影响[J]. 山东大学学报（医学版）, 2014, 52(12): 30-34.
[15]	贾宗洋,张向宁,靳艳慧,魏美玲. PD98059联合顺铂对卵巢癌细胞增殖的影响[J]. 山东大学学报(医学版), 2013, 51(2): 27-32.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed